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fered from high levels of anxiety, stress, and depression. The most frequent co-
morbidities included hypertension, coronary artery diseases, hyperlipidemia,
diabetes, obesity, depression, other skin diseases, and inflammatory bowel dis-
ease. Psoriasismay also confer an independent risk of acutemyocardial infarction.
CONCLUSIONS: Psoriasis was reported to have adverse effects on patients’ quality
of life including daily activities, social life, and productivity. Clinical burdens asso-
ciated with psoriasis included a number of serious co-morbidities. The evidence
retrieved as part of this systematic literature review well addressed the clinical
importance of psoriasis in Asia Pacific countries.
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OBJECTIVES: This study examined the opioid-sparing effectiveness, analgesic ef-
ficacy and tolerability of postoperative administration of parecoxib in total knee
arthroplasty (TKA) patients. METHODS: We performed a retrospective study of
enrollees received patient-controlled analgesia (PCA, consisted of morphine 1
mg/ml and fentanyl 30 mcg/ml) with or without single-dose of intravenous 40 mg
parecoxib following TKA from November 2010 through April 2011. Effect was as-
sessed by the amount of PCA used, pain intensity, length of hospital stay (LOS),
satisfaction score and adverse events. RESULTS: Nine patients under PCA with
parecoxib as the parecoxib group and 73 patients without parecoxib as the con-
trolled group were evaluated. PCA consumption was observed to be reduced in the
parecoxib group by 17.2 %, 25.5 % and 39.8 % less than the controlled group at 24 h,
48 h, and 72 h after surgery. Pain at movement improved significantly at 48 h and
72 h for the parecoxib group with visual analogue score (VAS). There were no
significant differences in pain scores at rest and LOS, however, between those who
received parecoxib or not. Satisfaction was described as “good, fair, and poor” by 0
%, 89%, and 11% in the parecoxib group, respectively, comparedwith 4%, 81%, and
15 % of the controlled group. The overall incidences of adverse events were re-
ported for 78 % of patients with parecoxib and 71 % of patients without parecoxib.
CONCLUSIONS: In this study, postoperative administration of parecoxib demon-
strated benefit in terms of PCA consumption and VAS score at movement. There-
fore, it seemed that parecoxib provided opioid-sparing and analgesic effect. Also,
the parental preparation of parecoxibmay be especially useful when patients were
unable to take oral medication or were experiencing nausea and vomiting.
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OBJECTIVES:Obesity and overweight constitute a significant public health issue in
New Zealand. The aim of this systematic review was to formally assess the evi-
dence on the effectiveness of selected obesity interventions. METHODS: The first
phase of this research involved a wide-ranging scoping search of the literature to
identify population-based obesity-prevention interventions. The search was con-
ducted using the Embase andMedline databases, a general internet search and via
the contributions of the stakeholder reference group. A total of 95 relevant primary
prevention interventionswere found, with 38 of these assessed in Australia or New
Zealand. The research team and the stakeholder reference group considered the
results of the scoping search and selected 16 interventions that appeared to be
effective using a weight-based outcome for full systematic review. RESULTS: The
selected interventions were based on both nutrition and physical activity in a
variety of age groups and settings (pre-school, school, tertiary education, commu-
nity, primary care and workplace). Interventions generally showed greater reduc-
tions in body mass index (BMI), BMI z-score, weight, weight to height ratio, waist
circumference and the incidence of being overweight or obese compared with
controls. In a school-basednutrition andphysical activity intervention inAustralia,
children in the intervention group gained significantly less weight compared with
the control group (-0.92 kg; P0.03). In a study of general health screening con-
ducted in Denmark, the body mass index of adults receiving the intervention in-
creased 0.6 kg/m2 less that those not receiving the intervention. CONCLUSIONS: A
number of interventions were shown to have the potential to prevent obesity in a
range of populations and settings. Themost cost-effective interventions for obesity
prevention were a school-based programme for children and general health
screening and advice for adults in a primary care setting.
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OBJECTIVES: Lead toxicity has been labeled as a major health problem globally
with limited therapeutic options. Literature reveals controversial reports on the
lead detoxifying potential of ascorbic acid (vitamin C). The aim of this study was to
see if vitamin C supplementation reduces lead levels of blood in adult subjects
exposed to lead.METHODS:After ethical approval and informed consent the traffic
police study subjects (all male) were randomly divided into two groups each con-
taining 40 subjects. One group received 500 mg vitamin C, while the second group
was given 1000 mg orally daily for a period of one month. Blood samples were
collected at 0, 15, and 30 days of treatment and lead levels were analyzed from the
PCSIR Lab, Karachi using atomic absorption spectrophotometer. RESULTS: The
data showed raised levels of lead in study subjects of both groups (21.74 1.62 and
22.51  1.28 mcg/dl; mean  SEM; N40) compared to the safe limit ( 10 mcg/dl)
recommended by WHO. The treatment with vitamin C (500 mg) reduced the lead
levels to 16.91 1.08mcg/dl (N29) after 15 days treatment (P0.01), while the lead
level after 30 days treatment was further reduced to12.61  1.50 mcg/dl (N  36;
p0.001 compared to control, 21.74  1.62). In the second group subjects, which
received 1000 mg vitamin C, the lead level after 15 days treatment was 15.800.89
mcg/dl (N 33; P0.001)), with no further drop (P0.05) after 30 days treatment, as
the resultant lead levelwas 14.64 1.05mcg/dl (N31).CONCLUSIONS:These data
indicate that vitamin C has a dose and time-dependent lead-detoxifying effect and
that vitamin C supplementation may be an effective, safe and economical method
in reducing blood lead levels in chronically exposed subjects such as traffic police.
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OBJECTIVES:A validated screening tool for the diagnosis of fibromyalgia (ACR 2010
FM-STD) had been introduced in Thailand. The aim of this study is to explore with
the FM-STD the prevalence of fibromyalgia (FM) and estimate its burden of disease
(BOD) within the community of Bangkok, Thailand. METHODS: A cross-sectional
nonclinical survey process was conducted in urban and suburban Bangkok during
August-December 2011. The questionnaire was designed to collect data related to
pain, likelihood of FM diagnose, pain impact and treatment patterns. Primary in-
terviewswere conducted by field researchers. Every respondent, whose scoresmet
the diagnostic criteria of FM,were subsequently referred to further investigation by
our research physicians who confirmed final diagnoses of those cases. RESULTS:
One thousand respondents fromvarious socio-economic backgrounds participated
in the survey. Six of them (0.6%) were medically found positive to FM; their mean
age (range): was 47.67 (33-63) years. Mean widespread pain index (WPI) and symp-
tom severity (SS) scale score (range): 10.17 (7-16) and 7.83 (7-12), respectively. Lower
back and right shoulder girdle were the first and second most frequent pain loca-
tions. Intermittent throbbing pain was the most general presentation among FM
cases. For key FM features, all six respondents reported, mild to severe intensity
fatigue and waking unrefreshed while altogether cognitive impairment was re-
ported unproblematic. Furthermore, FM had strong impact to daily activities, par-
ticularly for sleep, walk and routine work. Mean ability to accomplish work de-
clined up to 71.67% (60%-90%). All cases required aminimum onemonthly therapy
to manage their pain symptoms; massage/spa being the most frequent treatment
method selected in this study. Average monthly out-of-pocket expense, related to
pain management was US$16.11 (0-33.33). CONCLUSIONS: This is the first epide-
miological survey of FM in Thailand. Therefore, study’s findings will generate a
better understanding of FM problem among Thai health care providers.
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OBJECTIVES: To describe the prevalence and treatment status of hemophilia A
(HA), hemophilia B (HB), hemophilia C (HC) and Von Willebrand disease (VWD) in
mainland China based on existing data, and to estimate the cost of switching from
on-demand therapy to prophylaxis.METHODS:We conducted a systematic litera-
ture review in Aug, 2011 using PubMed, EMBASE, and Cochrane Library in English
and CBM, CNKI, VIP, Wanfang Database in Chinese. No retrieval limitation was set.
In addition, we carried out a search of general and targeted hemophilia related
websites. Reference lists of key reviews were hand-searched for further relevant
researches. Studies providing data of prevalence or cost of hemophilia inmainland
China were included. Meta-analysis was done using the generic inverse variance
model. RESULTS: 22 epidemiological and 16 economic studies were included for
the analysis. The weighted prevalence of hemophilia (HAHBHCVWD) was 3.6
per 100,000 (95%CI: 2.7-4.9 per 100 000).We estimated the number of hemophiliac in
mainland china to be 49,339 based on the data from the 6th nationwide census. The
official registration number of hemophiliac now is 9804. More than 50% of hemo-
philiacs inmainlandChinawere un-treated or treated occasionally. In the choice of
treating product, less than 50% used pure blood coagulation factors. Less than 10%
received prophylaxis. Based on the cost-effective study, low dose prophylaxis was
a cost-saving strategy compared to on-demand therapy. The frequency of bleeding
could be reduced by 80% and the life of hemophiliac would be close to normal if
extra CNY2.66 billion (CNY53845per case) were invested every year.
CONCLUSIONS: The prevalence of hemophilia in mainland China is underesti-
mated. Registration management has to be improved. Patients with hemophilia
lack treatment generally. It is practical to consider switching the treatment of
hemophilia from on-demand therapy to low dose prophylaxis.
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